DEVELOPMENT AND EVALUATION OF RAMOSETRON HYDROCHLORIDE MOUTH DISSOLVING THIN FILM FOR ENHANCED THERAPEUTIC EFFICACY AND PALATABILITY

MAHENDRA C. GUNDE; AVDHOOT D. PIMPALE; CHETAN GAIKWAD; MANGESH D. GODBOLE

doi:10.22159/ijap.2023v15i5.47422

Authors

MAHENDRA C. GUNDE Datta Meghe College of Pharmacy, DMIHER, Wardha-442001, Maharashtra, India. Kamla Nehru College of Pharmacy, Nagpur-441108, Maharashtra, India https://orcid.org/0000-0002-4427-0358
AVDHOOT D. PIMPALE Datta Meghe College of Pharmacy, DMIHER, Wardha-442001, Maharashtra, India
CHETAN GAIKWAD Kamla Nehru College of Pharmacy, Nagpur-441108, Maharashtra, India
MANGESH D. GODBOLE Dadasaheb Balpande College of Pharmacy, Nagpur-440037, Maharashtra, India https://orcid.org/0000-0002-3918-8114

DOI:

https://doi.org/10.22159/ijap.2023v15i5.47422

Keywords:

Mouth dissolving thin film, Ramosetron HCl, Folding endurance, HPMC, Vomiting, Irritable bowel syndrome

Abstract

Objective: Many people have difficulties in swallowing traditional dosage forms such as tablets and capsules. The goal of this study was to develop the mouth-dissolving thin film of Ramosetron HCl (RH) for quick onset of action in the treatment of vomiting and irritable bowel syndrome, with the added benefit of disguising the bitter taste of RH.

Methods: The solvent-casting approach was employed to formulate mouth dissolving thin film. The effect of variable concentrations and different grades of hydrophilic polymer HPMC (E5, E15 and E50), and plasticizers like glycerol and PEG 400 on disintegration time, drug release, thickness, tensile strength, percent elongation, folding endurance, and on appearance were studied. The optimized batch was kept for stability study at40±2 °C/75±5% RH for 30 d.

Results: The formed films were transparent with a smooth surface texture. The thickness, weight variation, drug content and pH of the surface were within acceptable limits. Tensile strength and folding endurance values demonstrated adequate mechanical strength. In 45 seconds, the formulation F6 comprising HPMC E5 (150 mg) and HPMC E15 (150 mg) with PEG 400 (0.4 ml) disintegrated. The F6 formulation released 98.78±0.96 %drug in 8 min and considered as optimal formulation. The taste masking of drug was evaluated by a taste perception study using volunteers. The optimized batch was found to be stable at 40±2 °C/75±5% RH for 30 d.

Conclusion: The concentration of hydrophilic polymers and plasticizers had a significant effect on the formulation and assessment characteristics of thin film. Mannitol assisted in masking the bitter taste of RH.

Downloads

Download data is not yet available.

References

Lodhi DS, Singh Panwar A, Golani P, Verma M. A review of the combination of xanthine and bronchodilator drug in mouth dissolving film for asthma treatment. Asian J Pharm Clin Res. 2021;14(11):24-9. doi: 10.22159/ajpcr.2021.v14i11.43091.

Cyriac JM, James E. Switch over from intravenous to oral therapy: a concise overview. J Pharmacol Pharmacother. 2014;5(2):83-7. doi: 10.4103/0976-500X.130042, PMID 24799810.

Dagli RJ, Sharma A. Polypharmacy: a global risk factor for elderly people. J Int Oral Health. 2014;6(6):i-ii. PMID 25628499.

Leung AK, Hon KL. Motion sickness: an overview. Drugs Context. 2019;8. doi: 10.7573/dic.2019-9-4. PMID 32158479.

Suresh BS, Hemraj MT. Design and statistical optimization of mouth dissolving sublingual film of fixed-dose combination of doxylamine succinate and pyridoxine hydrochloride using design of experiment in the treatment of nausea and vomiting in pregnancy. Asian J Pharm Clin Res 2018;11(12). doi: 10.22159/ajpcr.2018.v11i12.27978.

Wadetwar RN, Ali F, Kanojiya P. Formulation and evaluation of fast dissolving sublingual film of paroxetine hydrochloride for treatment of depression. Asian J Pharm Clin Res. 2019;12:126-32. doi: 10.22159/ajpcr.2019.v12i10.34690.

Maddela S, Nalluri BN. Development of zolmitriptan mouth dissolving films: formulation variables, mechanical properties, and in vitro drug release studies. Asian J Pharm Clin Res. 2019;12:273-9. doi: 10.22159/ajpcr.2019.v12i4.32176.

PS, N VG, Dv G, Sivadasu P. Formulation and evaluation of oral disintegrating film of atenolol. Asian J Pharm Clin Res 2018;11(8):312-5. doi: 10.22159/ajpcr.2018.v11i8.26464.

Sevinc Ozakar R, Ozakar E. Current overview of oral thin films. Turk J Pharm Sci. 2021;18(1):111-21. doi: 10.4274/tjps.galenos.2020.76390. PMID 33634686.

Pathare YS, Hastak VS, Bajaj AN. Polymers used for fast disintegrating oral films: a review. Int J Pharm Sci Rev Res. 2013;21:169-78.

Mishra A, Pathak AK. Plasticizers: a vital excipient in novel pharmaceutical formulations. Curr Res Pharm Sci. 2017;7(1):1-10. doi: 10.24092/CRPS.2017.070101.

Snejdrova E, Dittrich M. Pharmaceutically used plasticizers. Recent Adv Plast 2012. doi: 10.5772/39190.

Haju SS, Yadav S. Formulation and evaluation of cilnidipine mucoadhesive buccal film by solvent casting technique for the treatment of hypertension. Int J Pharm Pharm Sci. 2021;13:34-43. doi: 10.22159/ijpps.2021v13i9.42641.

Kaur P, Garg R. Oral dissolving film: present and future aspects. J Drug Delivery Ther. 2018;8(6):373-7. doi: 10.22270/jddt.v8i6.2050.

Fukudo S, Kinoshita Y, Okumura T, Ida M, Akiho H, Nakashima Y. Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women. Gastroenterology. 2016;150(2):358-66.e8. doi: 10.1053/j.gastro.2015.10.047, PMID 26551550.

Bi X, Liu X, Di L, Zu Q. Improved oral bioavailability using a solid self-micro emulsifying drug delivery system containing a multi-component mixture extracted from Salvia miltiorrhiza. Molecules. 2016;21(4):456. doi: 10.3390/molecules21040456, PMID 27070565.

PH, Fatima S. Formulation and evaluation of oral fast dissolving films of naproxen sodium. Int J Curr Pharm Sci 2022;14(2):48-53. doi: 10.22159/ijcpr.2022v14i2.1953.

Pallavi K, Pallavi T. Formulation and evaluation of fast dissolving films of eletriptan hydrobromide. Int J Curr Pharm Sci. 2017;9(2):59. doi: 10.22159/ijcpr.2017v9i2.17386.

Roy A, Arees R, Blr M. Formulation development of oral fast-dissolving films of Rupatadine fumarate. Asian J Pharm Clin Res. 2020;13:67-72. doi: 10.22159/ajpcr.2020.v13i11.39185.

Kumar S, Doddayya H. Fabrication and evaluation of mouth-dissolving films of domperidone. Int J Curr Pharm Res. 2023;15:36-43.

Vineetha VC, Mathews MM. Development and evaluation of dental films containing an antibacterial agent for the treatment of periodontitis. Int J Pharm Pharm Sci. 2015;7:52-9.

Maheswari KM, Devineni PK, Deekonda S, Shaik S, Uppala NP, Nalluri BN. Development and evaluation of mouth-dissolving films of amlodipine besylate for enhanced therapeutic efficacy. J Pharm (Cairo). 2014;2014:520949. doi: 10.1155/2014/520949. PMID 26556197.

Daud A, Peepliwal A, Bonde M, Sapkal N, Gaikwad N. Design and development of nicotiana tabacum flim using factorial design. Int J Pharm Pharm Sci. 2016;8(8):115-23.

Yassin GE, Abass HA. Design and evaluation of fast dissolving oro-dispersible films of metoclopramide hydrochloride using 32 multifactorial designs. Int J Pharm Pharm Sci. 2016;8:218-22.

Cilurzo F, Cupone IE, Minghetti P, Buratti S, Gennari CGM, Montanari L. Diclofenac fast-dissolving film: suppression of bitterness by a taste-sensing system. Drug Dev Ind Pharm. 2011;37(3):252-9. doi: 10.3109/03639045.2010.505928, PMID 20704459.

Meher A, Dighe NS. An overview of the fast-dissolving oral film. J Drug Delivery Ther 2019;9(4-s):822-5. doi: 10.22270/jddt.v9i4-s.3428.

Bobde SS, Tank HM. Design, characterization and statistical optimization of ramosetron hydrochloride mouth dissolving film using design of experiment. Int J App Pharm. 2019;11:224-30. doi: 10.22159/ijap.2019v11i2.30952, doi: 10.22159/ijap.2019v11i2.30952.